Engineered Production of Short-Chain Acyl-Coenzyme A Esters in Saccharomyces cerevisiae. by Krink-Koutsoubelis, Nicolas et al.
UC Berkeley
UC Berkeley Previously Published Works
Title
Engineered Production of Short-Chain Acyl-Coenzyme A Esters in Saccharomyces cerevisiae.
Permalink
https://escholarship.org/uc/item/0ms113jv
Journal
ACS synthetic biology, 7(4)
ISSN
2161-5063
Authors
Krink-Koutsoubelis, Nicolas
Loechner, Anne C
Lechner, Anna
et al.
Publication Date
2018-04-01
DOI
10.1021/acssynbio.7b00466
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
Engineered Production of Short-Chain Acyl-Coenzyme A Esters in
Saccharomyces cerevisiae
Nicolas Krink-Koutsoubelis,†,‡,¶ Anne C. Loechner,†,‡,¶ Anna Lechner,§,¶,⊗ Hannes Link,†,‡
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ABSTRACT: Short-chain acyl-coenzyme A esters serve as intermediate compounds in fatty acid biosynthesis, and the
production of polyketides, biopolymers and other value-added chemicals. S. cerevisiae is a model organism that has been utilized
for the biosynthesis of such biologically and economically valuable compounds. However, its limited repertoire of short-chain
acyl-CoAs eﬀectively prevents its application as a production host for a plethora of natural products. Therefore, we introduced
biosynthetic metabolic pathways to ﬁve diﬀerent acyl-CoA esters into S. cerevisiae. Our engineered strains provide the following
acyl-CoAs: propionyl-CoA, methylmalonyl-CoA, n-butyryl-CoA, isovaleryl-CoA and n-hexanoyl-CoA. We established a yeast-
speciﬁc metabolite extraction protocol to determine the intracellular acyl-CoA concentrations in the engineered strains.
Propionyl-CoA was produced at 4−9 μM; methylmalonyl-CoA at 0.5 μM; and isovaleryl-CoA, n-butyryl-CoA, and n-hexanoyl-
CoA at 6 μM each. The acyl-CoAs produced in this study are common building blocks of secondary metabolites and will enable
the engineered production of a variety of natural products in S. cerevisiae. By providing this toolbox of acyl-CoA producing
strains, we have laid the foundation to explore S. cerevisiae as a heterologous production host for novel secondary metabolites.
KEYWORDS: metabolic engineering, S. cerevisiae, heterologous pathway, precursor engineering, platform molecules, acyl-coenzyme A
S accharomyces cerevisiae, a model organism in the bio-technology industry, has been identiﬁed and established as
a versatile host for the biosynthesis of several natural and
engineered small molecules that comprise a number of diﬀerent
biochemical classes, such as ﬂavonoids, isoprenoids, alkaloids
and polyketides.1−4 There is great potential to use S. cerevisiae
for the production of unique secondary metabolites by
introducing many of the metabolic production routes that
have evolved in plants, fungi or bacteria. The ﬁrst step toward
such plug and play production in yeast, however, is availability
of biosynthetic precursors. Despite the many advantages as a
production host, S. cerevisiae lacks a number of short-chain acyl-
CoA metabolites required in the biosynthesis of many
biologically and economically important compounds.
One example are the polymers poly-3-hydroxybutyrate-co-3-
hydroxyvalerate (PHBV) and 2-hydroxybutyrate-containing
polyhydroxyalkanoate (2HB-PHA).5−7 Propionyl-CoA is as
platform metabolite in the biosynthesis of both PHA variants,
but not an intermediate of central metabolism in S. cerevisiae.5−7
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Other examples include linear, odd-chained and branched
organic acids and alcohols.8,9 These compounds are promising
alternatives to petroleum-based fuels10,11 and can be derived
from fatty acid biosynthesis. Saturated straight fatty acids are
synthesized from acetyl-CoA and malonyl-CoA both of which
are common to yeast, while odd-chain fatty acids require
propionyl-CoA12,13 and branched-chain fatty acids are
produced from short, branched-chain acyl-CoAs, such as
isovaleryl-CoA.14,15 Isovaleryl-CoA is not an intermediate in
yeast metabolism, and as such limits the production of odd-
chain and branched acids in S. cerevisiae.
Finally, many pharmaceutically relevant secondary metabo-
lites are polyketides. Polyketides comprise a vastly diverse
group of bioactive compounds made by polyketide synthases
(PKSs) in bacteria, fungi, plants and animals. PKSs condense
simple acyl-CoA building blocks, so-called starter and extender
units, via successive rounds of decarboxylative Claisen-like
condensations into chemically more complex products.16 Some
PKSs show an inherent substrate ﬂexibility that could be
exploited by feeding alternative carboxylates/caryboxyl-CoAs
and various alkylmalonyl-CoA extender units for the
production of new compounds with bioactive or special
chemical properties.17−19 Implementing an increasing variety
of characterized bio- and semisynthetic routes to diﬀerent acyl-
CoAs in S. cerevisiae would allow virtually endless possibilities
to create novel and non-natural chemicals in yeast.20−29
To expand the metabolic capabilities of yeast, we introduced
biosynthetic metabolic pathways to ﬁve diﬀerent acyl-CoA
esters into S. cerevisiae. Isovaleryl-CoA was produced via the
alternative isovaleryl biosynthetic (AIB) pathway from
Myxobacterium xanthus, which is the ﬁrst heterologous
expression example of the AIB pathway to our knowledge.30
We also report for the ﬁrst time production of n-butyryl-CoA
and n-hexanoyl-CoA in S. cerevisiae via the n-butanol (BUT)
pathway, which has been previously established in E. coli.9,31
Propionyl-CoA was produced both from glucose using the 3-
hydroxypropionate biosynthetic route (3HP) and by propio-
nate feeding using propionyl-CoA synthetase (PrpE).32−34
Propionyl-CoA synthesis via the PrpE route has been reported
in S. cerevisiae before and serves as benchmark to the
performance of the 3HP pathway.34 A biosynthetic route via
the 3HP pathway has been established in E. coli previously and
further improved here for production in S. cerevisiae.32
Methylmalonyl-CoA was synthesized via propionyl-CoA using
multiple pathways, including the 3HP and PrpE path-
ways.19,34,35 Methylmalonyl-CoA synthesis from sugar via the
3HP pathway has not be shown before in S. cerevisiae.
With the successful implementation of these biosynthetic
routes in S. cerevisiae, we have established yeast as a viable
production host for a variety of compounds. The engineered
strains can serve as a platform to implement pathways for the
production of value added chemicals, ranging from alcohols,
acids, to biopolymers and (un)natural fatty acids and
polyketides.
■ RESULTS AND DISCUSSION
Pathway Design. To avoid homologous recombination,
heterologous DNA fragments containing similar sequences are
Figure 1. Evaluation of several acyl-CoA extraction methods. Relative extraction eﬃciencies achieved for isovaleryl-CoA using diﬀerent extraction
methods (EM). For EM 1−4, a culture volume corresponding to a total OD600 of 10 was used; for EM 5−8, a total OD600 of 50 was used. For EM 1,
2, 5, and 6, cells were lysed using ﬁltration and quenching. For EM 3, 4, 7 and 8, cells were lysed by homogenization in quenching solution. The
extracted metabolite solution was additionally lyophilized in EM 2, 4, 6, and 8 and resuspended in 150 μL quenching solution. Bars show mean
values of two biological replicates ± standard deviation with highest measured intracellular concentration set as 100%.
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usually integrated into diﬀerent locations of the S. cerevisiae
genome. In this study we assembled the diﬀerent biosynthetic
pathway genes into cassettes. This cassette design allows for
greater engineering ﬂexibility and ultimately for rapid
integration into multiple loci. To allow for fast and convenient
cloning in a standardized fashion, a small cloning library (pNK
series) was generated based on the yeast 2 μ plasmids pRS425
and pRS424. This library contains pairs of glycolytic promoters
and terminators to be combined with any gene of interest and
assembled into pathway cassettes.36,37 The current library can
be used to create pathways with up to ﬁve genes (Figure S1).
We observed some variability for all intracellular acyl-CoA
levels. This could be attributed to the fact that all heterologous
genes were expressed from 2 μ plasmids, which are known to
have copy number variability.38 Alternatively, a part of the
variability might come from acyl-CoA ester instability during
metabolite extraction and analysis. All biosynthetic genes for
each pathway are colocalized on one construct, therefore
multiple integrations into diﬀerent loci can be achieved in the
future to reduce variability and at the same time increase gene
copy number.
Optimization of Acyl-CoA Metabolite Extraction. Acyl-
CoAs are diﬃcult to quantify in cell extracts, because they are
prone to hydrolysis and degradation. To prevent degradation
we optimized the metabolite extraction protocol. We used the
yeast strain expressing the AIB pathway genes as a test case for
method optimization. Figure 1 summarizes the diﬀerent
extraction methods (EM) tested and their relative extraction
eﬃciencies. Our results showed that using mechanical force
(i.e., homogenization) to disrupt the cell wall was necessary to
achieve eﬃcient extraction. Furthermore, we observed that
concentration steps by lyophilization strongly reduced meas-
urable titers up to 90% in our hands, probably due to acyl-CoA
instability under tested conditions. From these results, we chose
extraction method EM3 as the standard extraction protocol for
our study. EM3 is based on a total cell amount of OD600 10,
includes a bead beating step and recovers acyl-CoAs in almost
6-fold higher concentrations compared to the original
extraction method EM1. Method EM3 was applied for all
metabolite extractions. We quantiﬁed the concentration of each
acyl-CoA ester based on a calibration curve of synthesized
standards using LC−MS/MS and calculated intracellular
Figure 2. Scheme of gene cassettes encoding pathway enzymes and their respective acyl-CoA products. Each engineered pathway contains between
one to ﬁve biosynthetic genes and was assembled with unique promoter and terminator pairs.
Table 1. Product Titers for Each Acyl-CoA Pathway in S. cerevisiae
pathway description titer in μM for acyl-CoA (producta)
AIB alternative isovaleryl-CoA biosynthesis 5.5 ± 1.2 (iv-CoA)
3HP 3-hydroxypropionate route 8.5 ± 3.7 (p-CoA)
3HP-CCR 3-hydroxypropionate route with carboxylase/reductase 3.7 ± 2.7 (p-CoA) 0.3 ± 0.3 (mm-CoA)
PrpE propionyl-CoA synthetase 5.3 ± 2.4 (p-CoA)
PrpE-PCC1 propionyl-CoA synthetase with propionyl-CoA carboxylase (AccA1, PccB1) 4.6 ± 2.2 (p-CoA) 0.5 ± 0.1 (mm-CoA)
PrpE-PCC2 propionyl-CoA synthetase with propionyl-CoA carboxylase (AccA1, PccB1, PccE) and biotin ligase 6.8 ± 2.8 (p-CoA) 0.1 ± 0.1 (mm-CoA)
BUT n-butanol/hexanol pathway 6 ± 1.9 (but-CoA) 5.8 ± 2 (hex-CoA)
aAbbreviations are p-CoA, propionyl-CoA; iv-CoA, isovaleryl-CoA; mm-CoA, methylmalonyl-CoA; but-CoA, butyryrl-CoA; hex-CoA, hexanoyl-
CoA.
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metabolite pools taking cell concentration and extraction
volume into account.
Especially for unstable metabolites, the development of a
suitable and most importantly gentle extraction method is
necessary. Diﬀerent methods available are not speciﬁc to acyl-
CoA quantiﬁcation in S. cerevisiae or require additional
equipment and could hence not be applied in our case.39,40
Ultimately, improved extraction yields were achieved for the
desired process by comparing and combining commonly used
approaches.
Engineered Acyl-CoA Precursor Supply. Precursor
supply is pivotal to establishing S. cerevisiae as a production
host for various secondary metabolites. We therefore
engineered several acyl-CoA pathways into S. cerevisiae to
provide the commonly used precursors isovaleryl-CoA, butyryl-
CoA, hexanoyl-CoA, propionyl-CoA and methylmalonyl-CoA
(Figure 2). We based our pathway design on previously
characterized biosynthetic and catabolic routes. To this end we
established seven diﬀerent acyl-CoA pathways in S. cerevisiae to
create a diverse platform for secondary metabolite production.
The selected pathways supply the straight-chain starter units
propionyl-CoA, butyryl-CoA and hexanoyl-CoA, as well as the
branched-chain starter unit isovaleryl-CoA. Additionally, multi-
ple pathway routes were tested for the production of the
extender unit methylmalonyl-CoA. The average intracellular
concentration measured for each acyl-CoA is listed in Table 1.
Isovaleryl-CoA Supply. Certain bacteria and fungi produce
branched-chain acyl-CoAs using various pathways.41,42 One
biosynthetic scheme is based on the bacterial route via the
branched-chain α-keto acid dehydrogenase complex
(Bkd).43−45 We initially attempted to express this complex
together with a transaminase from Bacillus subtilis in S. cerevisiae
BJ5464, but did not observe any branched-chain acyl-CoA
production. This is likely due to the fact that a post-
translational modiﬁcation of the E2 subunit is required for its
activity.46 Lipoic acid is covalently bound to a lysine residue in
the lipoyl domain of the E2 subunit. However, in yeast the
lipoylation enzymes are localized to the mitochondrial lumen,
where they post-translationally modify the pyruvate and 2-
oxoglutarate dehydrogenase complexes.47 We additionally
attempted to engineer a cytosolic lipoic acid-scavenging
pathway by coexpressing the lipoyl ligase LplJ from B. subtilis.48
To this end, we constructed the Bkd pathway as well as a
cytosolic lipoylation route but were not able to detect any
branched-chain acyl-CoAs.42,48 As biosynthesis via the Bkd
pathway utilizes a multisubunit complex, it is likely that no
functional enzymes were formed under the conditions tested.
Potential bottlenecks could be an unfavorable ratio of Bkd
subunits and/or improper folding of its polypeptide chains as
well as diﬀerent expression dynamics preventing assembly of a
functional Bkd complex.
Alternatively, isovaleryl-CoA can be produced by branching
oﬀ the mevalonate pathway via the alternative isovaleryl-CoA
biosynthetic pathway (AIB) from M. xanthus.30 As in
mevalonate production, biosynthesis of isovaleryl-CoA is
initiated by condensation of two molecules of acetyl-CoA to
form acetoacetyl-CoA by a β-ketothiolase and conversion to 3-
hydroxy-3-methylglutaryl-CoA (HMG-CoA) is catalyzed by the
HMG-CoA synthase. The AIB pathway then diverts HMG-
CoA into 3-methylglutaconyl-CoA (MG-CoA) using the
hydratase LiuC. This reaction is followed by an AibA/B-
dependent decarboxylation yielding 3,3-dimethylacrylyl-CoA
(DMA-CoA), and the ﬁnal AibC-catalyzed reduction step leads
to formation of isovaleryl-CoA (Figure 3A).49 When expressing
the aib genes on a 2 μ plasmid in S. cerevisiae BJ5464, we were
able to detect isovaleryl-CoA in the prepared intracellular
Figure 3. Engineered production of isovaleryl-CoA via the alternative isovaleryl-CoA pathway (AIB). (A) Biosynthetic scheme toward isovaleryl-
CoA (iv-CoA) production: Proteins catalyzing the conversion of acetyl-CoA to HMG-CoA are native to yeast (black), whereas the 3-
methylglutaconyl CoA hydratase LiuC, the glutaconate CoA transferase AibA/B and the dehydrogenase AibC originate from M. xanthus (light blue).
(B) Intracellular concentrations of isovaleryl-CoA with respective standard deviations for three biological replicates of S. cerevisiae BJ5465 harboring
pNK23 (light blue) or the empty vector control pRS424 (black).
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metabolite extracts (Figure S2A). The intracellular concen-
tration was measured at 5.5 ± 1.2 μM, and no isovaleryl-CoA
was detected in the empty vector control extracts (Figure 3B).
Previously, it was shown that bacterial fatty acid synthases
(FAS) may also incorporate branched-chain acyl-CoAs, aside
from acetyl and malonyl-CoA.50 Recent advances in expanding
the substrate speciﬁcity of fungal FAS lay the foundation for the
exploration of synthesis of novel fatty acids by providing
unnatural, short-chain acyl-CoAs.51 For polyketides, isovaleryl-
CoA and other branched-chain acyl-CoAs serve as starter units
and the levels of acyl-CoAs produced within this study are
consistent with the reported binding constants for various
characterized PKSs.52−54 The intracellular concentrations of
acyl-CoAs, including isovaleryl-CoA, measured in this study are
comparable to acyl-CoAs pool sizes of natural producer strains,
suggesting that the engineered pathways can support polyketide
biosynthesis in yeast.55 As such, this engineered yeast strain can
serve as a platform to convert isovaleryl-CoA into various high-
value chemicals like polyketides or novel fatty acids.
Butyryl-CoA and Hexanoyl-CoA Production. Butyralde-
hyde and butanol production have been previously engineered
into E. coli and S. cerevisiae.9,31,56−60 To implement butyryl-CoA
and hexanoyl-CoA supply in yeast, we adapted the n-butanol
pathway previously described in E. coli for expression in
S. cerevisiae.9,31 The thiolase BktB condenses two acetyl-CoAs
into acetoacetyl-CoA. The dehydrogenase/reductase PaaH1
and the crotonase Crt catalyze the reactions to 3-
hydroxybutyryl-CoA and crotonyl-CoA, respectively. The
reductase Ter hydrogenates the penultimate intermediate to
form butyryl-CoA (Figure 4A). BktB from Ralstonia eutropha
has been shown to have good catalytic activity on butyryl-CoA,
which allows for an additional condensation toward synthesis of
hexanoyl-CoA.9,57 By expressing the n-butanol pathway in
S. cerevisiae, we could detect butyryl-CoA and hexanoyl-CoA
production in the engineered strain BJ5464 harboring pNK44
(Figure S2B). We determined intracellular concentrations of 6
± 1.9 μM for butyryl-CoA and 5.8 ± 2 μM for hexanoyl-CoA
(Figure 4B). Butyryl-CoA and hexanoyl-CoA are precursors to
alcohols and carboxylic acids.9 Several type I, II and III PKSs
have been shown to incorporate hexanoyl-CoA into (un)-
natural polyketides.61−63 By providing a S. cerevisiae platform
strain producing hexanoyl-CoA and additional other short- and
medium-chain acyl-CoAs, the establishment of yeast as
polyketide production host has been accelerated.
Propionyl-CoA Production. Multiple propionyl-CoA
biosynthesis routes exist in nature. The most commonly used
pathway is based on exogenous propionate supply and the
expression of the propionyl-CoA synthetase PrpE from
Salmonella typhimurium.34 To avoid propionate feeding, we
implemented a direct propionyl-CoA production route from
malonyl-CoA (Figure 5A). This pathway has been previously
established in E. coli and uses elements from the 3-
hydroxypropionate (3HP) carbon assimilation cycle found in
certain auxotrophic archaea and bacteria.32,64−66 We modiﬁed
the reported 3HP pathway by replacing McrSt, a malonic
semialdehyde reductase from Sulfolobus tokodaii, with the
bifunctional malonyl-CoA reductase McrCa from Chlorof lexus
aurantiacus.65 A recent study showed that McrCa has
signiﬁcantly higher activity compared to McrSt.
32,67,68 The
McrCa catalyzes two reduction steps from malonyl-CoA to 3-
hydroxypropionate, which is followed by an esteriﬁcation by the
3-hydroxypropionyl-CoA synthase (3Hpcs) of Metallosphaera
sedula to 3-hydroxypropionyl-CoA. The dehydration reaction
to acryloyl-CoA is catalyzed by the hydroxypropionyl-CoA
dehydratase (3Hpcd) of S. tokodaii. The ﬁnal reduction toward
propionyl-CoA is catalyzed by the acryloyl-CoA reductase Acr
from M. sedula (Figure 5A). After transforming the 3HP
pathway plasmid into S. cerevisiae BJ5464, we determined the
intracellular propionyl-CoA concentration to be 8.5 ± 3.7 μM
(Figure 5B, Figure S2C). We also recapitulated the PrpE-
dependent pathway for comparison and determined the
propionyl-CoA level to be 5.3 ± 2.4 μM. Side-by-side
comparison between both engineering approaches revealed
that propionate-dependent production resulted in a smaller
propionyl-CoA pool compared to the 3HP pathway (Figure
5B). Also, the PrpE dependent pathway showed a distinct
growth phenotype compared to the 3HP pathway and all other
acyl-CoA production pathways tested. While all strains
expressing pathways for the production of acyl-CoA esters
exhibited some reduced growth and ﬂocculation, probably
caused by changes in intracellular acyl-CoA (and free CoA)
pools, PrpE expression compromised growth only in the
Figure 4. Engineered production of butyryl-CoA (but-CoA) and hexanoyl-CoA (hex-CoA) via the BUT pathway. (A) Biosynthetic scheme from
acetyl-CoA via the beta-ketothiolase BktB from R. eutropha, the 3-hydroxyacyl-CoA dehydrogenase PaaH1 from Clostridium acetobutylicum, the
crotonase Crt from C. acetobutylicum and the trans-enoyl-CoA reductase Ter from Treponema denticola. (B) Intracellular concentrations of but-CoA
and hex-CoA with respective standard deviations for four biological replicates of the production strain BJ5465 harboring pNK44 (blue) or the empty
vector control pRS424 (black).
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presence of propionate in the medium (Table S4).89 This
indicated a toxic eﬀect of highly eﬃcient ATP-dependent
propionyl-CoA ligation in yeast.69−72 Overall we implemented
successful production of the platform molecule propionyl-CoA
via diﬀerent routes. Propionyl-CoA is a building block in
polyketides, fatty acids and bioplastics. Our strains facilitate the
implementation of production of these value-added chemicals.
Methylmalonyl-CoA Production. To supply the pre-
cursor methylmalonyl-CoA (mm-CoA) production we modi-
ﬁed the 3HP biosynthetic pathway by replacing the acryloyl-
CoA reductase Acr with a crotonyl-CoA carboxylase/reductase
(Ccr). These enzymes are able to reductively carboxylate enoyl-
CoA esters into their corresponding alkylmalonyl-CoA
analogs.73,74 We used the Ccr from Caulobacter crescentus
(CcrCc, Figure 5A) that was shown to convert acryloyl-CoA to
methylmalonyl-CoA in vitro.19 Using LC−MS/MS both
propionyl-CoA and methylmalonyl-CoA were detected at
intracellular concentrations of 3.7 ± 2.7 μM and 0.3 ± 0.3
μM, respectively (Figure 5B, Figure S2C). Recent inves-
tigations on the mechanism demonstrated that Ccrs are able to
catalyze a single reduction step in addition to the combined
reduction/carboxylation step, which explains the presence of
propionyl-CoA in addition to methylmalonyl-CoA.75,76 The
ratio of the two products indicates that reduction is more
eﬃcient compared to carboxylation under the tested conditions
in vivo.
An alternative route to mm-CoA using the PrpE-PCC
pathway has been published previously.34 Here we compared
the PrpE-PCC biosynthetic route with the 3HP-CCR pathway.
To this end, we established the ATP-dependent carboxylation
of propionyl-CoA, catalyzed by the biotin-dependent propion-
yl-CoA carboxylase complex (Pcc). The Pcc complex from
Streptomyces coelicolor consists of three subunits and requires a
post-translational modiﬁcation. The alpha subunit AccA1
contains two components, the biotin carboxylase and biotin-
carboxyl carrier protein domain. The beta subunit PccB1
functions as carboxyl transferase carboxylating propionyl-CoA
to form methylmalonyl-CoA. This mm-CoA biosynthetic
pathway has been successfully implemented in the past using
a multiplasmid approach.34 In this study we combined prpE,
accA1 and pccB1 on one plasmid creating the PrpE-PCC1
pathway. As this pathway produces propionyl-CoA as
intermediate, we detected both propionyl-CoA and methyl-
malonyl-CoA. The titer was measured at 0.5 ± 0.1 μM for
methylmalonyl-CoA, similar to the amount produced by the
3HP-CCR pathway. Propionyl-CoA was measured at an
intracellular concentration of 4.6 ± 2.2 μM (Figure 5B).
Then, we sought to improve mm-CoA levels by engineering
the PCC2 pathway comprised of AccA1, PccB1, PccE from
S. coelicolor and BirA from E. coli. Expression of the epsilon
subunit PccE has been found to improve complex formation
and increase Pcc activity signiﬁcantly.77−79 Furthermore, the
biotin ligase BirA has been shown to facilitate biotinylation of
the Pcc complex.35 The PrpE-PCC2 pathway was found to
produce a higher propionyl-CoA titer at 6.8 ± 2.8 μM but a
lower titer of methylmalonyl-CoA at 0.1 ± 0.1 μM compared to
the PrpE-PCC1 pathway. Reasons may lie in the varied design
of the genetic constructs, as prpE is expressed from a diﬀerent
promoter. It is also likely that complex formation of AccA1,
PccB1 and PccE is suboptimal under the here tested conditions,
forming more nonfunctional protein. To this end, we
successfully implemented a number of pathways resulting in
the production of methylmalonyl-CoA and quantiﬁed their
intracellular pools by LC−MS/MS.
Figure 5. Propionyl-CoA (p-CoA) and methylmalonyl-CoA (mm-CoA) production via the various biosynthesis routes. (A) Biosynthetic schemes
from malonyl-CoA or propionate using the malonyl-CoA reductase McrCa from C. aurantiacus, the 3-hydroxypropionyl-CoA synthase 3Hpcs from
M. sedula, the 3-hydroxypropionyl-CoA dehydratase 3Hpcd from S. tokodaii, the acryloyl-CoA reductase Acr from M. sedula, the propionyl-CoA
synthetase PrpE from S. typhimurium, the biotin-dependent propionyl-CoA carboxylase complex Pcc from S. coelicolor. Acryloyl-CoA can be reduced
and carboxylated via either a two-step pathway using Acr and the Pcc complex or the crotonyl-CoA carboxylase/reductase Ccr from C. crescentus. (B)
Intracellular propionyl-CoA concentrations in the 3HP production strain BJ5465 pNK30 (purple) and the PrpE production strain BJ5465 pNK36
(green). Intracellular concentrations of propionyl-CoA and methylmalonyl-CoA of the 3HP-CCR production strain BJ5465 pNK42 (orange), the
PrpE-PCC1 and PrpE-PCC2 production strains BJ5465 pNK37 or BJ5465 pNK54 (red) and the empty vector control strain BJ5465 pRS424 (black)
as well as their respective standard deviations. All concentrations were determined using three biological replica.
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■ CONCLUSION
To conclude, we metabolically engineered the budding yeast
S. cerevisiae to produce propionyl-CoA, butyryl-CoA, isovaleryl-
CoA, hexanoyl-CoA and methylmalonyl-CoA. We expressed
the alternative isovaleryl-CoA pathway of M. xanthus in yeast.
We also engineered S. cerevisiae for butyryl-CoA and hexanoyl-
CoA production via the well-established n-butanol pathway.
Finally, we evaluated multiple routes toward propionyl-CoA
and methylmalonyl-CoA biosynthesis and established a feeding-
free approach for the production of these acyl-CoA esters in
vivo. In summary, this study provides a foundation for
establishing S. cerevisiae as a general chassis for the production
of secondary metabolites, where the diﬀerent acyl-CoAs serve
as important platform molecules. The engineered platform
strains provide a metabolic engineering tool to produce diverse
compounds of interest such as fatty acids and polyketides from
renewable carbon sources in S. cerevisiae. This plug-and-play
approach further provides opportunities to discover and
engineer novel bioactive compounds and valuable chemicals
in the future.
■ MATERIALS AND METHODS
Strains and Plasmids. E. coli strain NEB Turbo (New
England Biolabs) was used for cloning and plasmid
propagation. S. cerevisiae BJ5465 was obtained from ATCC as
a protease-deﬁcient variant of S. cerevisiae (Meyen ex. E.C.
Hansen, ATCC 208289) (Table 2).80 The yeast 2 μ plasmids
pRS424 and pRS425 were chosen as vector backbones for acyl-
CoA pathway expression.81 The glycolytic promoters PTEF1,
PADH1, PPGK1, PFBA1 and PTDH3 were chosen based on their
expression strength and dynamic proﬁles using a published data
set.36 The selected promoters were previously shown to have
comparable activity during mid-log phase. The terminators
TCYC1, THXT7, TTDH3, TATC1, TADH1, TENO1, TSSA1 and TPGK1 were
selected based on their eﬃciency to terminate transcription as
characterized previously.36,37 Promoters and terminators used
in the BUT pathway were selected to investigate inducible
expression of enzymes for cell growth decoupled production of
acyl-CoA esters. All biosynthetic genes were codon optimized
for S. cerevisiae using the IDT codon optimization tool, except
for the 3HP pathway, which was sourced from E. coli codon
optimized genes, as well as birA, which was ampliﬁed from the
genome of E. coli.32 The mcrCa gene was kindly provided by the
Nielsen lab.82 The complete set of genes and their source
organisms are listed in Table S1.
We constructed the pathway plasmids in a modular approach
using a small library of entry vectors, which we generated
during this study and named the pNK series. The pNK
plasmids carry distinct promoter-terminator pairs to construct
gene expression cassettes in a modular approach. This small
library was then used as template to assemble all pathway
plasmids. A complete list of plasmids is provided in Table 3 and
Table S2, and a complete list of primers used for plasmid
assembly is available in Table S3. Each promoter, terminator,
gene and backbone was ampliﬁed by PCR and each primer had
an approximately 25-bp overhang to the ﬂanking parts.
Amplicons were generated by PCR using the high ﬁdelity
polymerase PrimeSTAR GXL DNA (Clontech) and S. cerevisiae
CEN.PK as gDNA template or described plasmids. The
puriﬁed PCR products were assembled using circular polymer-
ase extension cloning (CPEC) or Gibson assembly.83,84
Puriﬁed PCR fragments were used as input for CPEC, with
250 ng backbone and 3:1 amount of insert to vector in a 50 μL
reaction volume. Five μL of the assembled plasmid was
transformed into E. coli using electroporation. Analytical digests
and subsequent sequencing identiﬁed correct plasmids. For
Gibson assembly, 100 ng backbone was mixed with inserts (3:1
insert to backbone molar ratio) in a 10 μL reaction volume, of
which 5 μL was added to the cells for transformation. 100 ng of
the backbone amplicon was cotransformed with the insert
fragments in a 1:3 ratio into competent S. cerevisiae BJ5465 cells
using the Frozen-EZ Yeast Transformation II Kit (Zymo
Research). A more detailed description of plasmid construction
can be found in the Supporting Information.
Media and Cultivation. E. coli cells were routinely cultured
in Luria−Bertani medium (LB) containing 100 μg/mL
ampicillin for plasmid propagation at 37 °C. S. cerevisiae cells
were grown at 30 °C in yeast extract-peptone-dextrose (YPD)
medium consisting of 1% bacto yeast extract, 2% bacto peptone
and 2% dextrose. Yeast strains carrying plasmids were grown at
30 °C on selective plates (Trp dropout or Leu dropout) and at
25 °C for liquid cultures. A modiﬁed synthetic complete
medium was used for selective growth in liquid medium.
Synthetic complete medium was purchased from Sunrise
Scientiﬁc lacking Tryptophan (SC-TRP) or Leucine (SC-
LEU). The modiﬁed synthetic complete medium contained
13.4 g/L yeast nitrogen base, 5.76 g/L SC-TRP or 5.49 g/L
SC-LEU, 20 g/L glucose and 100 mM sodium phosphate buﬀer
Table 2. Strains Used in This Study
strain genotype and description reference
E. coli NEB
Turbo
gln V44 thi-1 Δ(lac-proAB) galE15 galK16
R(zgb-210::Tn10)TetS endA1 Δ(mcrB-
hsdSM)5, (rK
−mK
−) F′ [traD36 proAB+ lacIq
lacZΔM15/fhuA2]
NEB
S. cerevisiae
BJ5465,
ATCC
208289
MATa ura3−52 trp1 leu2-Δ1 his3-Δ200
pep4::HIS3 prb1-Δ1.6R can1 GAL
ATCC34,80
Table 3. Plasmids Used in This Studya
plasmid genotype and description reference pathway
pNK23 PTEF1-aibA-TPGK1 PPGK1-aibC-TADH1 PADH1-aibB-THXT7 PFBA1-liuC-TTDH3, 2 μ, TRP1, AmpR-pMB1 This study AIB
pNK30 PTEF1-mcr-TPGK1 PADH1-acr-THXT7 PFBA1-3hpcd- TTDH3 PTDH3-3hpcs-TACT1, 2 μ, LEU2, AmpR-pMB1 This study 3HP
pNK36 PTDH3-prpE-TACT1, 2 μ, TRP1, AmpR-pMB1 This study PrpE
pNK37 PTDH3-prpE-TACT1 PTEF1-accA1- TTDH3 PPGK1-pccB1-THXT7, 2 μ, TRP1, AmpR-pMB1 This study PrpE-PCC1
pNK42 PTEF1-mcr-TCYC1 PADH1-ccr-THXT7 PFBA1-3hpcd-TTDH3 PTDH3-3hpcs-TACT1, 2 μ, LEU2, AmpR-pMB1 This study 3HP-CCR
pNK44 PGAL1-paaH1-TENO1 PGAL10-bktB-TSSA1 PGAL7-ter-TADH1 PTEF2-crt-TPGK1, 2 μ, LEU2, AmpR-pMB1 This study BUT
pNK54 PTDH3-pccE-TACT1 PFBA1-prpE-TTDH3 PADH1-birA-THXT7 PTEF1 -accA1-TADH1 PPGK1-pccB1-TCYC, 2 μ, TRP1, AmpR-pMB1 This study PrpE-PCC2
aAll plasmids were expressed in S. cerevisiae BJ5465.
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pH 6.4 and was used to grow the strains containing 2 μ
plasmids.
For intracellular acyl-CoA analysis, fresh single colonies were
prepared. Each plasmid was transformed into competent cells
of S. cerevisiae strain BJ5465 and plated onto selective growth
agar. The plates were incubated for 3 days at 30 °C. Precultures
were grown from single colonies in 5 mL selective SC medium
for 3 to 4 days at 25 °C. Production cultures were then
inoculated to a starting OD600 of 0.05 into 12 mL of selective
medium in 100 mL ﬂasks and grown at 25 °C and 200 rpm.
Strains carrying prpE expression plasmids were supplemented
with 50 mM sodium propionate to allow for propionyl-CoA
production. The cells were harvested after 48 h.
To determine growth rates, cells were freshly transformed
with plasmids. After growing for 3 days on plates, three colonies
were picked and cultured in 5 mL media for another 3 days.
Cells were then inoculated at an OD600 of 0.05 in 24-well plates
in 1.5 mL volume with diﬀerent sodium propionate
concentrations and grown for 70 h at 25 °C.89
Metabolite Extraction. The protocol for intracellular
metabolite extraction was adapted from a previous study.32 In
order to identify optimal extraction conditions for our purpose,
several commonly used extraction protocols were tested and
compared (Figure 1). S. cerevisiae transformed with plasmid
pNK23 producing isovaleryl-CoA was selected for utilization in
the extraction method optimization.
For the ﬁltration step of extraction method 1, 2, 5 and 6, a
culture volume corresponding to a total OD600 of 10 or 50 was
vacuum-ﬁltered through a 0.45-μm pore size ﬁlter. The ﬁlters
that collected the cells were immediately transferred into 1 mL
of quenching solution (prechilled acetonitrile/methanol/water
(2:2:1)) and incubated at −20 °C for at least 1 h.
Resuspended cells were transferred into 1.5 mL tubes and
centrifuged at −9 °C and 17 000g for 30 min. The supernatant
was stored at −80 °C for subsequent lyophilization or analysis
using liquid chromatography coupled to triple quadrupole mass
spectrometry (LC−MS/MS).
The same total OD600 of cells as above were harvested by
centrifugation for 3 min at −9 °C at 2700g and supernatant was
discarded for the extraction methods 3, 4, 7, and 8. Cells were
taken up in 1 mL of prechilled quenching solution and
transferred into 2 mL screw cap tubes, ﬁlled half with 0.5 mm
glass beads. Cells were homogenized 10 times for 10 s at 4800g
with 2 min on ice between each homogenization pulse
(Precellys Evolution, Bertin Instruments). To separate the
cell lysate from the beads, the lid of the tubes was removed and
a hole was poked into the bottom using a hot needle. The tube
containing the metabolite extract was then set into an empty 15
mL falcon, centrifuged for 2 min at 2700g and −9 °C, to
separate the extract from the beads. After removing the empty
homogenizer tube with the remaining beads, the ﬂow-through
cell suspension was transferred into prechilled 1.5 mL tubes
and centrifuged for at least 20 min at 17 000g and −9 °C to
remove any remaining cell debris. The supernatant was
transferred into a new tubes and the samples were subsequently
stored at −80 °C for lyophilization or LC−MS/MS analysis.
For extraction method 2, 4, 6 and 8, in which samples were
lyophilized, the stored supernatants were diluted with 5 mL
water and snap frozen in liquid nitrogen. Samples were
lyophilized (Alpha 1−4 LCS plus, Martin Christ) at −50 °C for
15 h. Samples were taken up in 150 μL quenching solution. Of
all samples, 3 μL were analyzed using LC−MS/MS.
To determine intracellular concentrations of all acyl-CoA
esters from production cultures, the cells were cultivated for 48
h at 25 °C at 200 rpm and a culture volume corresponding to a
total OD600 of 10 was harvested and extracted according to
extraction method 3 (Figure 1).
LC−MS/MS Analysis of Acyl-CoA Esters. Acyl-CoA
esters were measured by fast LC−MS/MS as described
previously.85 An Agilent 1290 Inﬁnity II UHPLC system
(Agilent Technologies) was used for liquid chromatography.
The column was an Acquity BEH Amide 30 × 2.1 mm with 1.7
μm particle size (Waters GmbH). The temperature of the
column oven was 30 °C, and the injection volume was 2 μL. LC
solvent A was water with 10 mM ammonium formate and 0.1%
formic acid (v/v), and LC solvent B was acetonitrile with 0.1%
formic acid (v/v). The gradient was 0 min 90% B; 1.3 min 40%
B; 1.5 min 40% B; 1.7 min 90% B; 2 min 90% B. The ﬂow rate
was 0.4 mL min−1. An Agilent 6495 triple quadrupole mass
spectrometer (Agilent Technologies) was used for mass
spectrometry using ion source parameters described in Guder
et al.86 Parameters for multiple reaction monitoring (MRM)
were adapted from Zimmermann et al. (Table 4).85 Absolute
concentrations of acyl-CoA esters were estimated by external
calibration curves. The corresponding acyl-CoAs were synthe-
sized according to a previous study.20 Butyryl-CoA and
propionyl-CoA were synthesized following the protocol for
Symmetric Anhydride Synthesis.20 For the hexanoyl-CoA,
isobyutyryl-CoA, 2-methylbutyryl-CoA and isovaleryl-CoA
synthesis, we used Carbonyldiimidazole Synthesis.20 Methyl-
malonyl-CoA was synthesized using malonic acid and the
malonyl-CoA synthetase MatB.20 The purity of the products
and yields were determined using HPLC−MS and Nanodrop
(Nanodrop 2000, Thermo Scientiﬁc). The stocks of the
compounds were stored at −80 °C and diluted into extraction
solution to use as standards for LC−MS/MS. All standards
were mixed at ﬁnal concentrations of 2.5, 0.625, 0.156, 0.039,
0.0098 and 0.0024 μM. From these calibration curves, the
absolute concentration of precursors in cell lysates were
determined. Intracellular concentrations were calculated using
a speciﬁc cell volume of 3.7 × 10−14 L/cell and 3 × 107 cells/
mL per OD600 1.
87,88
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